To try and understand al-l that is happening in multiple sclerosis (MS) research is in many ways an impossible task. The ideas and concepts, although initially simple and easily understood, quickly become lost in the avalanche of literature attempting to prove or disprove their validity. The reader, though at first excited at the prospect of unravelling the enigma of a disease affecting approximately 1 in 2000 in Britain, becomes frustrated and irritated at the often contradictory accounts and investigations. These problems arise from two major sources: the sheer clinical difficulty of staging accurately MS and thus patient selection and sample homogeneity; and problems in trying to penetrate and reflect accurately the complex interactions occurring in the central nervous system (CNS) where in vitro and peripheral monitoring techniques although valuable are fraught with error.
In some respects research into MS has failed. A century after the classical clinical description of Charcot it still baffles with its unknown cause, erratic pattern and variable coursel. There is no convincing therapy available and the consequences to the patient seem to depend on the whim ofthe disease, regardless of any clinical practice. Yet inroads are being made, headed by the twin vehicles of virology and immunology; it is the new ideas in these disciplines and the interactions between themthat now leads any attempt to investigate the pathogenesis of MS.
As a foundation to any possible mechanisms the epidemiological and genetic results that have been generated are needed, since they have played a large part in directing developments.
Epidemiology and genetics
If the outstanding findings were outlined in a paragraph, excepting all inherent diffculties,-artifacts and inaccuracies from such work they would be as follows: the strong correlation of MS prevalence with increasing latitude (despite acknowledgedexceptions such as the Japanese, Eskimos and Hungarian gypsies) pointing towards an environmental agent2;
the clustering that appears to take place within given latitudes (for example in Finland there is a clustering in the Western regions) suggesting a locally operating environmental factor3; and the observation that migration before the age of adolescence carries a risk equal to that of the country of origin4, implying that any factor that operates is more potent in childhood. It is these, combined with the apparent 'outbreaks' of MS in some North Atlantic island populations particularly the Faroe Islands5 that suggest an infectious aetiological agent, non-transmissible (there appears to be no conjugal association) and causing a latent primary damage probably early in life.-On the other hand, the variation in frequency of MS among different ethnic groups independently of latitude, and the higher risk found among relatives (a sib of a sufferer has approximately 15 times the probability of developing MS) compared with the sample population suggest a genetic factor to be important. It was the explosion of research that followed the identification of the human leukocytic antigen (HLA) system in the early 1970s,-that led to discoveries of association with certain haplotypes (in order of descending strength! DW2, DR2, B7 and A3). More recently a weaker link with IgG allotype genes, including Gm-1, 17, 21 and 26, has been found6.
Yet if a genetic influence alone was to be the sufficient cause of the disease, 100% concordance would theoretically be expected of MS in monozygotic twins. Present studies, however, show this to be in the order of 40-50%. It must share a role though, as part of a multifactorial process, because the concordance rate of monozygotic twins as compared to. dizygotic twins is larger; 40-50% versus 15-20%7.
Current theories
The briefdiscussion above is direcd towards the two most popular theories of MS pathogenesis todaythe infectious (probably viral) and the autoimmune (greatly strengthened by HLA associations). These will be seen to be the two strongest threads that run through, cross over and cross back through any current ideas of the how, the when and the why of MS research today.
Simply put, the present framework of ideas is either of a purely viral cause; a purely autoimmune cause, or, most likely, a combination of the two processes. Thus it is thought that an immune reaction occurs, many years later, in genetically susceptible individuals directed against brain antigens, through a system sensitized by early childhood infections. This being said it is important not to become obsessive about the main ideas and be blinkered to other more peripheral data.
MS is generally considered not to be a-systemic disease and this discussion concentrates on the CNS components specifically for two reasons. Firstly, this is the area which is primarily involved in the disease, and secondly, as technical difficulties are solved it is from this region that the recent advances-have come.
The plaque
Traditionally MS has been described -as a relapsing 01410768/89/ and remitting disease that may eventually become 030159-04/$02.OO/O progressive or may be progressive from the outset. ©1989
The advent of more advanced scanning techniques The Royal including computed tomography, magnetic resonance Society of imaging and evoked potentials has challenged this Medicine notion and started to demonstrate that MS 'never sleeps'8, it being chronically progressive pathologically even if not clinically.
Oligodendrocytes
The characteristic lesion ofMS is the plaque, initially consisting of a perivenular inflammation in myelin containing regions ofthe CNS and finally progressing to dense scarring. The destruction of myelin with the preservation of axons characterizes demyelinatlng disorders and it is the selective loss of the myelinproducer cells, the oligodendrocytes, from the plaque that is now considered.
As in many other areas of MS research it is unclear whether the target under consideration is primarily or secondarily damaged (i.e. as an epiphenomenon). Current dogma has forced the search for antioligodendrocyte antibodies and although found, none have been shown to be specific for MS9"10. Similarly, experimental scenarios of direct viral oligodendrocyte infection such as Theiler's murine encephalomyelitis virus (TMEV)"1 and the JHM strain of mouse hepatitis virus (JHMV) injected into Lewis rats though showing how a virally induced autoimmune demyelination could be produced' (see below) have not been upheld in MS. The proposition ofoligodendrocytes as primary targets has never been popular, since their differential loss from the white matter does not reflect their usual even grey/white distribution. What might prove to be a hammer-blow to this idea is a recent observation that oligodendrocytes within fresh MS lesions seem to be normal in number and appearance'3.
Oligodendrocytes may play another role in MSthat of a remyelinating force. CNS remyelination occurs regularly following demyelination in most experimental systems. The myelin sheath of the remyelinated axon is thinner and the internodes are shorter than the primary myelinated tissue enabling new areas to be identified. It appears that although there is no evidence of remyelination in chronic lesions it takes place at the edges of active plaques'4. This has been used as one explanation of MS remissions.
Is there any evidence for the production of an abnormal myelin by the oligodendrocyte prior to the beginning of any inflammation? The answer appears to be conclusively no15. MS is a demyelinating rather than a dysmyelinating process.
Humoral response Immunoglobulins
The early lesion shows perivascular c1uffs containing lymphocytes, blasts, plasma cell& and monocytes. It would seem from past investigation that both immunoglobulin (Ig) and immunglobulin-producing cells are to be found in the subsequent plaques16. The characteristic elevation in Ig synthesis in MS patients can be calculated to result from an intrathecal source. Interestingly once established in a patient there is little subsequent change in its quality or quantity.
Recently isoelectric focusing was used to compare the IgG eluted from MS, subacute sclerosing panencephalitis (SSPE) and:> control brains'7. It was found that whereas in SSPE the--IgG was homogeneous, in MS individual plaques had distinct patterns. This gave rise to ideas of a variable re e to the same antigen, vrying antigens or the synthesis nonsense Igs. Further studies to exclude nonsense production using anti-idiotype antibodies have as yet been unable to show convincingly the universal crossreaction among MS patients which would presume the existence of an MS aetiologic agent/antigenic target'8.
It is the search for this target which has haunted studies since the thirties and the production of an (albeit imperfect) animal model for MS, namely experimental autimmune (allergic) encephalomye4t~s
(EAE), first demonstrated in rabbits after whole CNS material inoculation. Without going into detail, subsequent events showed the active encephalitogen to be a myelin protein known as myelin-basic protein (MBP) and indeed sequences within the molecule could be shown alone to induce EAE. However this earlier form was acute and monophasic-and it needed the development of a chronic, relapsing EAE to push on further attempts to isolate a similar encephalogen in MS19.. Yet despitehaving given invaluable imiRunological information, the MS overview is thit MBPdirected antibodies, although found, are secondary to the demyelinating process. A similar conclusion also looks likely for antibodies against the other neural antigens, e.g. proteolipid protein (PLP), myelin associated glycoprotein, galactocerebroside and gangliosides GM1 and GM4. This might be considered a premature statement when evidence has on occasions been produced purporting their demyelinating, inhibition of myelination and oligodendrocyte toxic effects in vitro20. However, overall a consensus argues against primary pathogenic roles: their presence in only 60% of MS patients, their low levels as a whole when found and representation in other non-autoimmune disease states such as SSPE and neurosyphilis2'.
Another look then at the increased amounts of Igs fbund in the CNS of-MS patients most readily examined via the cerebrospinal fluid -(CSF) that bathes it. The standard abnormalities are well documentedan elevated IgG in an oligoclonal pattern and a restricted heterogeneity of IgG subclass (IgG, predominating) allotype (Gml outweighing Gm3) and light chain isotype (an increased x/X ratio).
But what's new? A number of novel openings have started -to emerge.
First, has come an appreciation of -the other immunoglobulin classes. Approximate figures show a significant elevation of the CSF IgM in 50% of patients and IgA in 10-20%22, with calculation ofthe relevant indices indicating-an intrathecal source. IgA is of special interest because of its implications in many other immune mediated and viral diseases.
Secondly, over the years, has come the growing realization. that MS patients show an elevated titre (though small) of antibodies not to a single virus but to many viruses (often to several withinone patient) ranging from measles to human T cell lymphotropic (HThV)-lilqe viruses2. Unlike the oligocloxal bands from patients with a single well defined chronicviral infetin as in SSPE where up to 75%9ofthe I8G shows -the anti measles vius actijvt24. In MS the antiviral antibodies make up only a small proportion of the total o onal Ig and indeed for a statistically significantresult the data may often need to be aggregated.-
The sarch for an antigenic target for the oligoclonal Igs found in MS cerebrospinal fluid has thus been largely unfilled either neurally or virally. Therefore, the need to seek comfort in the ideas of the bulk of the Igs being nonsense antibodies or produced against an as yet undiscovered target. Such theories are expanded upon later.
Although the immunoglobulin component of the CSF/CNS has proved elusive, are there any other tracks to be followed?
Immune complexes
Immune complexes are now known to be responsible for a variety of immunological disease including systemic lupus erythematosus (SLE) and rheumatoid arthritis. Perhaps not unexpectedly in view ofthe circulating antibodies and antigens described above, corresponding complexes have been isolated25, although their concentration is low compared with the pathological states where they are the putative mediators26. Further studies have started to probe the dynamics of the complexes suggesting higher levels in chronic state than in exacerbations where antibodies such as the anti-MBP molecule seem to be released27. The significance of this to the MS process is questionable.
Viruses
At this point a return to an aspect already mentioned viral theories of pathogenesis.
Epidemiological evidence implicates an infectious agent, serological evidence points to a multidirected antiviral immune response (though it is weak). The obvious step therefore is to look for viral infiltration directly. Older methods such as isolation and electron microscopy identified a number ofpossible candidates which included Mycoplasma, protozoa, spirochaetes, the rabies virus, herpes simplex virus-2, parainfluenza type I, etc. Unfortunately, none of these were subsequently confirmed. By analogy with the kuru and Creutzfeldt-Jakob viruses which were not visualized directly but were recovered only by direct trnsmission to primates, similar efforts were made, again to prove negative. It has been the newer, more sensitive techniques from molecular virology that have reawakened hopes of direct detection. Nucleic acid hybridization using radiolabelled deoxyribonucleic acid (DNA) probes complementary to viral genomes has found evidence of measles and HTLV-I-like viruses28 (disputed29). These findings, though recognizing such sequences in approximately halfthe MS patients ted also showed them up in a similar number of controls, preventing an unequivocal conclusion. Back then to the advances made in known models ofviralinduced demyelination.
Viruses can induce demyelination lesions often resembling quite closely those seen in MS in a number of ways. The mechanisms involved might be direct viral lysis of the myelin producing cell (as in JHMV infection of mice) or viral infection leading to an immune response against normal host components. The autoimmune responses could theoretically be induced in the following ways: (1) if the envelope of budding virions bore host-determined as well as viral antigens; (2) cell destruction could lead to exposure of intracellular host antigens; (3) cross reaction may occur with determinants present on both viral and host antigens; (4) If an attempt is made to link both direct results, e.g. the persistence of viral antibodies to several viruses long after the acute infection has passed and other evidence of an immune response against viruses, with the indirect epidemiological evidence, a case can be made for the interaction of viruses with the immune system. The interaction may be the cause or a result of MS. By assuming it to be the cause the data now appears to back not one specific virus (e.g. as in the past measles, canine distemper viruses etc.) but many common viruses having a primary auto-'sensitizing' effect at an early age, rather than any direct effects. It seems likely that the sufferer would be especially susceptible to such a process and genetic associations in men and animals with MS and its counterparts have now started to appear (e.g. TMEV) and certain mice strains). Such a train ofevents is still far from proven or worked out in detail and should be treated as such.
Cell mediated immunity T cells A place for cell mediated immunity in the pathogenesis of MS stems from the histological appearance of actively demyelinating lesions, namely the mononuclear cells and numerous macrophages and astrocytes. Laterthis wasreinforced bydiscoveriesthatacute and probably chronic EAE could be passively transferred by MBP sensitized T cells but not with serum. These were found to be of helper/inducer type3O.
Unfortunately as in most areas of MS research, results in this area have been conflicting and thus confusing. Major problems exist with an incomplete understanding of normal T population/subpopulation interactions let alone the abnormal ones. This is compounded by the antigen of importance being unknown in MS. Initial studies were carried out on peripheral blood cells, but with the development of successful CSF cell cloning techniques and microsystems a more me "Alingful picture has started to emerge. The results examine two facets: the numbers and relative ratios of T subpopulations and functional alterations.
There have been many studies of levels of lymphocyte subjects, the recent ones employing monoclonal antibodies. They show an increased presence of central T cells, with the CD4+ phenotype predominating in the active plaque. Acceptance ofthe idea that MS 'never sleeps' implies that any attempts to link alterations in immunological parameters with clinical changes are likely to be fictitious. Reported correlations of, say, a reduction ofsuppressor activity with exacerbations are subject to technical errors (which monoclonal antibodies are employed, type of assessment used, etc.) clinical errors (in patient staging) and biological errors (e.g. circadian variation and T subpopulation heterogeneity). Therefore any such conclusions should be treated very carefully. That being said a reduction in the CD8+/CD4+ ratio does occur in some MS patients with evidence suggesting it in the CD8+ component that alters. Theoretically a decrease in this set could result from either a migration, e.g. into an active lesion, or a modulation of phenotype, e.g. by autoantibodies3 .
One ofthe most exciting results from 1980s neuroimmunology was the demonstration of IFN. and activated T cell induction of HLA components on previouslynegativebraincells, iallytheas and endothelium32. This has important implications as the cells could potentially be lysed by class I restricted Tr cells and present antigen with class H molecules which might cause augmentation/initiation of the demyelinating sequence. Cytochemical studies confirmed increased Ia+ cells around active! plaques, though these could be CD4+, B or macrophage besides astrocytes.
Macrophages
Finally IgG capping of macrophages has served to demonstrate the link between monocytes and antibodies, and show that antibody attack occurs in MS. Haematogenousmacrophagesprobablyplaythe leading role in myelin destruction at the advancing edge ofthe lesionthey are often found containing lipid33.
Conclusion
The goal ofresearch into multiple sclerosis must be. to treat and eventually prevent the disease. At present the theoretical basis of treatments which have been used, for example ACTH, steroids and anti-idiotype antibodies, continues to rest on unproven hypotheses concerning possible autoimmune or viral mechanism. On the one hand further manipulation ofchronic EAE has now produced models which resemble MS moreand more closely; on the other there is a failure to discover antibody or cell mediakted tests which reliably and reproducibly demonstrate an autoimmune response to antigens specifically in MS but not other neurological diseases. Furthermore, although epidemiological evidence implies an environmental agent and several experimental viral models can induce an MS-like demyelination, no one has demonstrated anything but circumstantial results to suggest the prime mediator as viral. There is no lack of hypotheses by which viral infection might generate an autoimmune response, and discoveries of antigen presenting cells in the CNS and computer generated areas of sequences that crossreact between viruses and the brain help to strengthen the argument. The immune system is abnormal in MS but whether this is the cause or just a result of the disorder is unknown. Until one of these ideas is proved, trials ofnew treatments based on uncertain facts will carry on and the, results are likely to reflect this.
